ABSTRACT
OBJECTIVE: To enhance the quality of care and clinical outcomes for children and adolescents with major depressive disorder (MDD) and persistent depressive disorder (PDD). The aims are as follows: (1) to summarize empirically based guidance about the psychosocial and psychopharmacologic treatment of MDD and PDD in children and adolescents; and (2) to summarize expert-based guidance about the assessment of these disorders as an integral part of treatment, and the implementation of empirically based treatments for these disorders in clinical practice. METHOD: Statements about the treatment of MDD and PDD are based upon empirical evidence derived from a critical systematic review of the scientific literature conducted by the Research Triangle Institute International-University of North Carolina at Chapel Hill (RTI-UNC) Evidence-based Practice Center under contract with the Agency for Healthcare Research and Quality (AHRQ). Evidence from meta-analyses published since the AHRQ/RTI-UNC review is also presented to support or refute the AHRQ findings. Guidance about the assessment and clinical implementation of treatments for MDD and PDD is informed by expert opinion and consensus as presented in previously published clinical practice guidelines, chapters in leading textbooks of child and adolescent psychiatry, the DSM-5-TR, and government-affiliated prescription drug information websites. RESULTS: Psychotherapy (specifically, cognitive-behavioral and interpersonal therapies) and selective serotonin reuptake inhibitor (SSRI) medication have some rigorous (randomized controlled trials, meta-analyses) empirical support as treatment options. Because effective treatment outcomes are predicated in part upon accuracy of the diagnosis, depth of the clinical formulation, and breadth of the treatment plan, comprehensive, evidence-based assessment may enhance evidence-based treatment outcomes. CONCLUSION: Disproportionate to the magnitude of the problem, there are significant limitations in the quality and quantity of rigorous empirical support for the etiology, assessment, and treatment of depression in children and adolescents. In the context of a protracted severe shortage of child and adolescent-trained behavioral health specialists, the demonstration of convenient, efficient, cost-effective, and user-friendly delivery mechanisms for safe and effective treatment of MDD and PDD is a key research need. Other research priorities include the sequencing and comparative effectiveness of depression treatments, delineation of treatment mediators and moderators, effective approaches to treatment nonresponders and disorder relapse/recurrence, long-term effects and degree of suicide risk with SSRI use, and the discovery of novel pharmacologic or interventional treatments.
Subject(s)
Antidepressive Agents , Depressive Disorder, Major , Adolescent , Child , Humans , Antidepressive Agents/therapeutic use , Depressive Disorder, Major/diagnosis , Depressive Disorder, Major/drug therapy , Psychotherapy , Selective Serotonin Reuptake Inhibitors/therapeutic use , Treatment OutcomeABSTRACT
Anxiety disorders are among the most common psychiatric disorders in children and adolescents. As reviewed in this guideline, both cognitive-behavioral therapy (CBT) and selective serotonin reuptake inhibitor (SSRI) medication have considerable empirical support as safe and effective short-term treatments for anxiety in children and adolescents. Serotonin norepinephrine reuptake inhibitor (SNRI) medication has some empirical support as an additional treatment option. In the context of a protracted severe shortage of child and adolescent-trained behavioral health specialists, research demonstrating convenient, efficient, cost-effective, and user-friendly delivery mechanisms for safe and effective treatments for child and adolescent anxiety disorders is an urgent priority. The comparative effectiveness of anxiety treatments, delineation of mediators and moderators of effective anxiety treatments, long-term effects of SSRI and SNRI use in children and adolescents, and additional evaluation of the degree of suicide risk associated with SSRIs and SNRIs remain other key research needs.
Subject(s)
Cognitive Behavioral Therapy , Serotonin and Noradrenaline Reuptake Inhibitors , Adolescent , Anxiety Disorders/drug therapy , Child , Humans , Serotonin , Selective Serotonin Reuptake InhibitorsABSTRACT
Intellectual disability (intellectual developmental disorder) (ID/IDD) is both a psychiatric disorder and a risk factor for co-occurring psychiatric disorders in children and adolescents. DSM-5 introduced important changes in the conceptualization and diagnosis of ID/IDD, and current research studies clarify assessment and treatment of co-occurring psychiatric disorders in this population. Optimal assessment and treatment of psychiatric illness in children and adolescents with ID/IDD includes modifications in diagnostic and treatment techniques, appreciation of variations in the clinical presentation of psychiatric disorders, an understanding of the spectrum of etiologies of behavioral disturbance, and knowledge of psychosocial and medical interventions.
Subject(s)
Intellectual Disability , Mental Disorders , Adolescent , Child , Comorbidity , Developmental Disabilities , Diagnostic and Statistical Manual of Mental Disorders , Humans , Intellectual Disability/diagnosis , Intellectual Disability/epidemiology , Intellectual Disability/therapy , Mental Disorders/diagnosis , Mental Disorders/epidemiology , Mental Disorders/therapy , Risk FactorsABSTRACT
This Practice Parameter describes the principles of psychodynamic psychotherapy with children and is based on clinical consensus and available research evidence. It presents guidelines for the practice of child psychodynamic psychotherapy, including indications and contraindications, the setting, verbal and interactive (play) techniques, work with the parents, and criteria for termination.
Subject(s)
Psychoanalytic Therapy/methods , Psychoanalytic Therapy/standards , Child , Child, Preschool , Follow-Up Studies , Humans , Internal-External Control , Long-Term Care , Psychoanalytic Interpretation , Psychotherapy, Brief/methods , Psychotherapy, Brief/standards , Self ConceptABSTRACT
This Parameter addresses the key concepts that differentiate the forensic evaluation of children and adolescents from a clinical assessment. There are ethical issues unique to the forensic evaluation, because the forensic evaluator's duty is to the person, court, or agency requesting the evaluation, rather than to the patient. The forensic evaluator clarifies the legal questions to be answered and structures the evaluation to address those issues. The forensic examination may include a review of collateral information, interviews and other assessments of the child or adolescent, and interviews with other relevant informants. The principles in this Parameter suggest the general approach to the forensic evaluation of children and adolescents and are relevant to delinquency, child custody, child maltreatment, personal injury, and other court-ordered and noncourt-ordered evaluations.
Subject(s)
Child Abuse/ethics , Child Abuse/legislation & jurisprudence , Child Abuse/psychology , Child Custody/ethics , Child Custody/legislation & jurisprudence , Ethics, Medical , Expert Testimony/ethics , Expert Testimony/legislation & jurisprudence , Forensic Psychiatry/ethics , Forensic Psychiatry/legislation & jurisprudence , Interview, Psychological/methods , Juvenile Delinquency/ethics , Malpractice/legislation & jurisprudence , Adolescent , Child , Confidentiality/legislation & jurisprudence , Humans , Juvenile Delinquency/legislation & jurisprudence , Juvenile Delinquency/psychology , Physician's Role , Psychotherapy/legislation & jurisprudence , United StatesSubject(s)
Defense Mechanisms , Psychoanalysis/history , Psychoanalytic Theory , Psychoanalytic Therapy/methods , Psychology, Child/history , Austria , Berlin , Bibliographies as Topic , Famous Persons , Freudian Theory , History, 20th Century , Humans , Latency Period, Psychological , Psychoanalysis/education , Psychoanalytic Therapy/education , Teaching/history , Transference, Psychology , United StatesABSTRACT
This Practice Parameter reviews the evidence from research and clinical experience and highlights significant advances in the assessment and treatment of posttraumatic stress disorder since the previous Parameter was published in 1998. It highlights the importance of early identification of posttraumatic stress disorder, the importance of gathering information from parents and children, and the assessment and treatment of comorbid disorders. It presents evidence to support trauma-focused psychotherapy, medications, and a combination of interventions in a multimodal approach.
Subject(s)
Stress Disorders, Post-Traumatic , Adolescent , Child , Humans , Parents , Practice Guidelines as Topic , Psychotherapy , Stress Disorders, Post-Traumatic/diagnosis , Stress Disorders, Post-Traumatic/therapyABSTRACT
This practice parameter describes the psychiatric assessment and management of physically ill children and adolescents. It reviews the epidemiology, clinical presentation, assessment, and treatment of psychiatric symptoms in children and adolescents with physical illnesses and the environmental and social influences that can affect patient outcome.
Subject(s)
Adolescent Psychiatry/methods , Child Psychiatry/methods , Acute Disease , Adolescent , Child , Child, Preschool , Chronic Disease , Humans , Mental Disorders/physiopathology , Mental Disorders/therapyABSTRACT
This practice parameter describes the epidemiology, clinical picture, differential diagnosis, course, risk factors, and pharmacological and psychotherapy treatments of children and adolescents with major depressive or dysthymic disorders. Side effects of the antidepressants, particularly the risk of suicidal ideation and behaviors are discussed. Recommendations regarding the assessment and the acute, continuation, and maintenance treatment of these disorders are based on the existent scientific evidence as well as the current clinical practice.